Baseline predictors of major adverse events for transthyretin amyloidosis cardiomyopathy patients treated and untreated with disease-modifying therapy PC57 (#216)

Robert JH. Miller

Steven Dykstra

Jonathan G. Howlett

Shireen Kassam

James A. White

Nowell M. Fine

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com